Xuefeng Liu Selected Research

dehydroandrographolide

1/2019	Dehydroandrographolide Inhibits Osteosarcoma Cell Growth and Metastasis by Targeting SATB2-mediated EMT.
10/2017	Protective effect of dehydroandrographolide on obstructive cholestasis in bile duct-ligated mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuefeng Liu Research Topics

Disease

62	Neoplasms (Cancer) 06/2022 - 03/2005
11	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 01/2019
10	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
8	Carcinogenesis 04/2020 - 09/2012
6	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2015
6	Esophageal Squamous Cell Carcinoma 01/2021 - 06/2018
5	Necrosis 01/2022 - 03/2013
5	Infections 01/2022 - 02/2009
5	Inflammation (Inflammations) 03/2021 - 01/2011
4	Carcinoma (Carcinomatosis) 01/2022 - 02/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 10/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2013
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 08/2010
3	Carcinoma in Situ 01/2022 - 03/2011
3	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2009
3	Cataract (Cataracts) 10/2021 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 03/2021 - 12/2013
3	Glioma (Gliomas) 01/2021 - 11/2016
3	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2018
3	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 01/2017
3	Albuminuria 07/2011 - 01/2007
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2016
2	Virus Diseases (Viral Diseases) 11/2020 - 02/2009
2	Adenocarcinoma 01/2020 - 02/2012
2	Hypersensitivity (Allergy) 01/2020 - 01/2018
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019 - 01/2015
2	Fibrosis (Cirrhosis) 01/2018 - 10/2017
2	Liver Neoplasms (Liver Cancer) 01/2017 - 05/2015
2	Chronic Hepatitis B 04/2014 - 05/2002
2	Sepsis (Septicemia) 01/2014 - 03/2013
2	Body Weight (Weight, Body) 09/2013 - 08/2012
2	Papillomavirus Infections 01/2009 - 09/2008
1	Drug Resistant Epilepsy 04/2022
1	Starvation 04/2022
1	Hypertrophy 01/2022
1	Low Back Pain (Lumbago) 01/2022
1	Malaria 01/2022

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
15	Pharmaceutical PreparationsIBA 03/2022 - 05/2002
12	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2013
6	Biological ProductsIBA 06/2022 - 01/2019
6	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2013
6	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 01/2014
6	Calcibiotic Root Canal SealerIBA 11/2020 - 02/2012
5	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 08/2012
5	Long Noncoding RNAIBA 01/2021 - 01/2017
5	rho-Associated KinasesIBA 06/2020 - 02/2012
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2015
5	CateninsIBA 09/2019 - 02/2012
5	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2013
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 03/2005
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2009
4	CytokinesIBA 01/2020 - 01/2011
4	Cadherins (E-Cadherin)IBA 01/2020 - 08/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 10/2013
3	TOR Serine-Threonine KinasesIBA 04/2022 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2016
3	LigandsIBA 01/2019 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2008
3	NF-kappa B (NF-kB)IBA 05/2016 - 02/2009
3	Messenger RNA (mRNA)IBA 09/2015 - 01/2009
2	AlbuminsIBA 04/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2021
2	Estrogens (Estrogen)FDA Link 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 03/2021 - 11/2016
2	Alkaline PhosphataseIBA 01/2021 - 01/2019
2	Amino Acids FDA Link 08/2020 - 05/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2016
2	Caspase 3 (Caspase-3)IBA 01/2019 - 03/2015
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2012
2	dehydroandrographolideIBA 01/2019 - 10/2017
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 05/2016
2	salicylhydroxamic acid (SHAM)IBA 02/2016 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 01/2011
2	Ethylene Glycol (Monoethylene Glycol)IBA 05/2015 - 03/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2015 - 08/2010
2	Triglycerides (Triacylglycerol)IBA 12/2013 - 09/2013
2	Antihypertensive Agents (Antihypertensives)IBA 10/2008 - 01/2007
1	Adenosine Triphosphatases (ATPase)IBA 04/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2022
1	Tight Junction ProteinsIBA 04/2022
1	Congo RedIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022

Therapy/Procedure

20	Therapeutics 04/2022 - 05/2002
6	Drug Therapy (Chemotherapy) 01/2020 - 10/2013
4	Precision Medicine 06/2020 - 07/2016
3	Immunotherapy 06/2021 - 03/2011
3	Radiotherapy 01/2019 - 01/2013
2	Transplantation 01/2020 - 01/2014
2	Vertebroplasty 09/2015 - 08/2015
2	Brachytherapy 02/2013 - 01/2013
1	Nephroureterectomy 01/2022